Results 121 to 130 of about 10,378 (206)

PATH-66. Double identity: molecular heterogeneity between liquid biopsy from the CSF and tissue samples of a multifocal, disseminated High-Grade Astrocytoma with Piloid Features (HGAP) in NF1 patient

open access: yesNeuro-Oncology
Abstract We describe a 46-year-old male with Neurofibromatosis type 1 (NF1) and a previously known parenchymal medullary mass identified in 2022, initially managed with surveillance. In late 2023, he developed a progressive brainstem syndrome prompting presentation to our center.
Dweik, Khaled   +6 more
openaire   +1 more source

Minimally invasive liquid biopsy analysis of B-cell non-Hodgkin lymphomas [PDF]

open access: yes, 2018
The gold standard for the diagnosis of tumors are tissue biopsies. However, sometimes it is not feasible to obtain a tissue biopsy due to a high risk of complications or difficult anatomical localizations.
Jiwa, L.S.
core  

The potential of liquid biopsy for detection of the KIAA1549-BRAF fusion in circulating tumor DNA from children with pilocytic astrocytoma [PDF]

open access: yes
Background Low-grade gliomas (LGGs) represent children’s most prevalent central nervous system tumor, necessitating molecular profiling to diagnose and determine the most suitable treatment.
Arthur, Cecilia   +23 more
core   +1 more source

Clinical trial status of exosomes‐based cancer theranostics

open access: yesClinical and Translational Discovery
Exosomes, are a subpopulation of extracellular vesicles, that originate from endosomes. The major role of exosomes is cellular communication (in this process exosomes display the status of the parental cell's nature, healthy or the cell suffers any ...
Swarup Sonar
doaj   +1 more source

BIOM-56. A FEASIBILITY STUDY UTILIZING SEQUENTIAL CEREBROSPINAL FLUID (CSF) - BASED LIQUID BIOPSY AND AMIDE PROTON TRANSFER (APT) MRI TO DIFFERENTIATE DISEASE PROGRESSION FROM RADIATION NECROSIS IN PATIENTS WITH BRAIN METASTASIS FROM SOLID TUMORS

open access: yesNeuro-Oncology
Abstract BACKGROUND Brain metastases affect 30–40% of patients with solid tumors, and as systemic therapies improve survival, intracranial recurrences are more common. Radiation therapy is standard of care treatment but can frequently lead to radiation necrosis, which can mimic tumor ...
Maia, MD, Catarina Martins   +12 more
openaire   +2 more sources

Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy

open access: yesSignal Transduction and Targeted Therapy
Immune checkpoint blockade (ICB) has revolutionized cancer treatment, but the therapeutic response is highly heterogeneous, which highlights the necessity for developing predictive biomarkers and overcoming ICB resistance. Cancer cell-intrinsic features,
Yufeng Guo   +9 more
doaj   +1 more source

Epigenetic Profiling of Cell-Free DNA in Cerebrospinal Fluid: A Novel Biomarker Approach for Metabolic Brain Diseases

open access: yesLife
Due to their clinical heterogeneity, nonspecific symptoms, and the limitations of existing biomarkers and imaging modalities, metabolic brain diseases (MBDs), such as mitochondrial encephalopathies, lysosomal storage disorders, and glucose metabolism ...
Kyle Sporn   +7 more
doaj   +1 more source

ID #1131 Predicting Early Tumor Progression in Patients with Atypical Teratoid/Rhabdoid Tumor with Longitudinal CSF Liquid Biopsies: A Report from Phase 2 Study (SJATRT) stratum B1.

open access: yesNeuro-Oncology Pediatrics
Abstract Background Atypical teratoid/rhabdoid (AT/RT) is an aggressive pediatric brain tumor, prevalent in children < 3 years(Y) of age; methylation profiles subclassify AT/RTs into AT/RT-MYC (MYC), AT/RT-SHH (SHH), and AT/RT-TYR (TYR). At the molecular level, AT/RT shows alterations in
Aditi Bagchi   +28 more
openaire   +1 more source

Case Report: Proteomic analysis of cerebrospinal fluid in a retinoblastoma patient

open access: yesFrontiers in Oncology
This study focuses on the proteomic analysis of cerebrospinal fluid (CSF) in a patient with stage III retinoblastoma (RB) with the aim to identify molecular changes associated with central nervous system (CNS) relapse.
Angela Galardi   +11 more
doaj   +1 more source

Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors [PDF]

open access: yes
IntroductionPrimary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin’s lymphoma that affects brain parenchyma, eyes, cerebrospinal fluid, and spinal cord. Diagnosing PCNSL can be challenging because imaging studies often show similar
Mengxue Zhang   +21 more
core   +1 more source

Home - About - Disclaimer - Privacy